No CrossRef data available.
Article contents
Outcomes in infective endocarditis among adults with CHD: a comparative national study
Published online by Cambridge University Press: 10 October 2024
Abstract
Background:
Given increased survival for adults with CHD, we aim to determine outcome differences of infective endocarditis compared to patients with structurally normal hearts in the general population.
Methods:
We conducted a retrospective cross-sectional study identifying infective endocarditis hospitalisations in patients 18 years and older from the National Inpatient Sample database between 2001 and 2016 using International Classification of Disease diagnosis and procedure codes. Weighting was used to create national annual estimates indexed to the United States population, and multivariable logistic regression analysis determined variable associations. Outcome variables were mortality and surgery. The primary predictor variable was the presence or absence of CHD.
Results:
We identified 1,096,858 estimated infective endocarditis hospitalisations, of which 17,729 (1.6%) were adults with CHD. A 125% increase in infective endocarditis hospitalisations occurred for adult CHD patients during the studied time period (p < 0.001). Adults with CHD were significantly less likely to experience mortality (5.4% vs. 9.5%, OR 0.54, CI 0.47–0.63, p < 0.001) and more likely to undergo in-hospital surgery (31.6% vs. 6.7%, OR 6.49, CI 6.03–6.98, p < 0.001) compared to the general population. CHD severity was not associated with increased mortality (p = 0.53). Microbiologic aetiology of infective endocarditis varied between groups (p < 0.001) with Streptococcus identified more commonly in adults with CHD compared to patients with structurally normal hearts (36.2% vs. 14.4%).
Conclusions:
Adults with CHD hospitalised for infective endocarditis are less likely to experience mortality and more likely to undergo surgery than the general population.
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press
References
Marelli, AJ, Ionescu-Ittu, R, Mackie, AS, Guo, L, Dendukuri, N, Kaouache, M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 2014; 130: 749–756.CrossRefGoogle ScholarPubMed
Verheugt, CL, Uiterwaal, CS, van der Velde, ET et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J 2011; 32: 1926–1934.CrossRefGoogle ScholarPubMed
Baumgartner, H, Bonhoeffer, P, De Groot, NM et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915–2957.Google ScholarPubMed
Moore, B, Cao, J, Kotchetkova, I, Celermajer, DS. Incidence, predictors and outcomes of infective endocarditis in a contemporary adult congenital heart disease population. Int J Cardiol 2017; 249: 161–165.CrossRefGoogle Scholar
Tutarel, O, Alonso-Gonzalez, R, Montanaro, C et al. Infective endocarditis in adults with congenital heart disease remains a lethal disease. Heart 2018; 104: 161–165.CrossRefGoogle ScholarPubMed
Mylotte, D, Rushani, D, Therrien, J et al.Incidence, predictors, and mortality of infective endocarditis in adults with congenital heart disease without prosthetic valves. Am J Cardiol 2017; 120: 2278–2283.CrossRefGoogle ScholarPubMed
Egbe, AC, Vallabhajosyula, S, Akintoye, E, Connolly, HM. Trends and outcomes of infective endocarditis in adults with tetralogy of fallot: a review of the national inpatient sample database. Can J Cardiol 2019; 35: 721–726.CrossRefGoogle ScholarPubMed
Bor, DH, Woolhandler, S, Nardin, R, Brusch, J, Himmelstein, DU. Infective endocarditis in the U.S., 1998–2009: a nationwide study. PLoS One 2013; 8: e60033.CrossRefGoogle ScholarPubMed
Thuny, F, Di Salvo, G, Belliard, O et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112: 69–75.CrossRefGoogle ScholarPubMed
Cabell, CH, Jollis, JG, Peterson, GE et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002; 162: 90–94.CrossRefGoogle ScholarPubMed
Prendergast, BD, Tornos, P. Surgery for infective endocarditis: who and when? Circulation 2010; 121: 1141–1152.CrossRefGoogle ScholarPubMed
Lalani, T, Chu, VH, Park, LP et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 2013; 173: 1495–1504.CrossRefGoogle ScholarPubMed
Funakoshi, S, Kaji, S, Yamamuro, A et al. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg 2011; 142: 836–842 e831.CrossRefGoogle ScholarPubMed
Otto, CM, Nishimura, RA, Bonow, RO et al.ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 2020; 143: e72–e227.Google Scholar
Bansal, A, Cremer, PC, Jaber, WA, Rampersad, P, Menon, V. Sex differences in the utilization and outcomes of cardiac valve replacement surgery for infective endocarditis: insights from the national inpatient sample. J Am Heart Assoc 2021; 10: e020095.CrossRefGoogle ScholarPubMed
Sambola, A, Fernandez-Hidalgo, N, Almirante, B et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol 2010; 106: 92–98.CrossRefGoogle Scholar
Dolgner, SJ, Arya, B, Kronman, MP, Chan, T. Effect of congenital heart disease status on trends in pediatric infective endocarditis hospitalizations in the United States between 2000 and 2012. Pediatr Cardiol 2019; 40: 319–329.CrossRefGoogle ScholarPubMed
Sakai Bizmark, R, Chang, RR, Tsugawa, Y, Zangwill, KM, Kawachi, I. Impact of AHA’s 2007 guideline change on incidence of infective endocarditis in infants and children. Am Heart J 2017; 189: 110–119.CrossRefGoogle ScholarPubMed
Bates, KE, Hall, M, Shah, SS, Hill, KD, Pasquali, SK. Trends in infective endocarditis hospitalisations at United States children’s hospitals from 2003 to 2014: impact of the 2007 American heart association antibiotic prophylaxis guidelines. Cardiol Young 2017; 27: 686–690.CrossRefGoogle ScholarPubMed
Pant, S, Patel, NJ, Deshmukh, A et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015; 65: 2070–2076.CrossRefGoogle ScholarPubMed
Mori, M, Brown, KJ, Bin Mahmood, SU, Geirsson, A, Mangi, AA. Trends in infective endocarditis hospitalizations, characteristics, and valve operations in patients with opioid use disorders in the United States: 2005–2014. J Am Heart Assoc 2020; 9: e012465.CrossRefGoogle ScholarPubMed
Compiled from 1990 to 1999 bridged-race intercensal population estimates (released by NCHS on 1997/1926/2004); revised bridged-race 2000-2009 intercensal population estimates (released by NCHS on 1910/1926/2012); and bridged-race Vintage 2015. United States Department of Health and Human Services (US DHHS) CfDCaPC, National Center for Health Statistics (NCHS). Bridged-Race Population Estimates, United States. July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin, 2010-2015. postcensal population estimates (released by NCHS on 1996/1928/2016). Available on CDC WONDER Online Database, http://wonder.cdc.gov/bridged-racev2015.html, Accessed 1996/1998/2021.Google Scholar
Schranz, AJ, Fleischauer, A, Chu, VH, Wu, LT, Rosen, DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med 2019; 170: 31–40.CrossRefGoogle ScholarPubMed
Agarwal, S, Sud, K, Menon, V. Nationwide hospitalization trends in adult congenital heart disease across 2003–2012. J Am Heart Assoc 2016; 5: e002330.CrossRefGoogle ScholarPubMed
Stout, KK, Daniels, CJ, Aboulhosn, JA et al. AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2018; 73: e81–e192, 2019.CrossRefGoogle Scholar
Rodriguez, FH 3rd Ephrem, G, Gerardin, JF, Raskind-Hood, C, Hogue, C, Book, W. The 745.5 issue in code-based, adult congenital heart disease population studies: relevance to current and future ICD-9-CM and ICD-10-CM studies. Congenit Heart Dis 2018; 13: 59–64.CrossRefGoogle ScholarPubMed
Gilboa, SM, Devine, OJ, Kucik, JE et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation 2016; 134: 101–109.CrossRefGoogle ScholarPubMed
Mylotte, D, Pilote, L, Ionescu-Ittu, R et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation 2014; 129: 1804–1812.CrossRefGoogle ScholarPubMed
Maser, M, Freisinger, E, Bronstein, L et al.Frequency, mortality, and predictors of adverse outcomes for endocarditis in patients with congenital heart disease: results of a nationwide analysis including 2512 endocarditis cases. J Clin Med 2021; 10: 5071.CrossRefGoogle ScholarPubMed
van Melle, JP, Roos-Hesselink, JW, Bansal, M et al. Infective endocarditis in adult patients with congenital heart disease. Int J Cardiol 2022; 370, 178–185.CrossRefGoogle ScholarPubMed
Cahill, TJ, Jewell, PD, Denne, L et al. Contemporary epidemiology of infective endocarditis in patients with congenital heart disease: a UK prospective study. Am Heart J 2019; 215: 70–77.CrossRefGoogle ScholarPubMed
Murdoch, DR, Corey, GR, Hoen, B et al.Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med 2009; 169: 463–473.CrossRefGoogle ScholarPubMed
Abdelghani, M, Nassif, M, Blom, NA et al. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc 2018; 7: e008163.CrossRefGoogle ScholarPubMed
Mir, T, Uddin, M, Qureshi, WT, Regmi, N, Tleyjeh, IM, Saydain, G. Predictors of complications secondary to infective endocarditis and their associated outcomes: a large cohort study from the national emergency database (2016–2018).. Infect Dis Ther 2022; 11: 305–321.CrossRefGoogle ScholarPubMed
Selton-Suty, C, Celard, M, Le Moing, V et al. Preeminence of staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012; 54: 1230–1239.CrossRefGoogle ScholarPubMed
Marques, A, Cruz, I, Caldeira, D et al. Risk factors for in-hospital mortality in infective endocarditis. Arq Bras Cardiol 2020; 114: 1–8.Google ScholarPubMed
Kim, JH, Lee, HJ, Ku, NS et al. Infective endocarditis at a tertiary care hospital in south Korea. Heart 2021; 107: 135–141.CrossRefGoogle Scholar
Davtyan, A, Guyon, PW, El-Sabrout, HR et al. Selective valve removal for melody valve endocarditis: practice variations in a multicenter experience. Pediatr Cardiol 2022; 43: 894–902.CrossRefGoogle Scholar
Chan, T, Pinto, NM, Bratton, SL. Racial and insurance disparities in hospital mortality for children undergoing congenital heart surgery. Pediatr Cardiol 2012; 33: 1026–1039.CrossRefGoogle ScholarPubMed
Salciccioli, KB, Salemi, JL, Broda, CR, Lopez, KN. Disparities in insurance coverage among hospitalized adult congenital heart disease patients before and after the affordable care act. Birth Defects Res 2021; 113: 644–659.CrossRefGoogle ScholarPubMed
Byrne et al. supplementary material
Byrne et al. supplementary material
File
32.2 KB